Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jhe-Cyuan Guo

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
International Journal of Clinical Oncology|October 1, 2013
Sequential gemcitabine and platinum versus first-line combination of gemcitabine and platinum for advanced pancreatic cancer treatment: a retrospective studyJhe-Cyuan Guo, Shih-Hung Yang
Esophagus : Official Journal of the Japan Esophageal Society|January 23, 2025
Exploring novel immunotherapy in advanced esophageal squamous cell carcinoma: Is targeting TIGIT an answer?Chien-Huai Chuang, Jhe-Cyuan Guo, Ken Kato, et al.
Journal of Clinical Medicine|July 31, 2019
Postoperative Imaging and Tumor Marker Surveillance in Resected Pancreatic CancerHsu Wu, Jhe-Cyuan Guo, Shih-Hung Yang, et al.
Cancers|February 13, 2025
Impact of Membranous Nectin-4 on Outcomes of Platinum-Based Chemotherapy in Metastatic Urothelial CarcinomaFu-Jen Hsueh, Chung-Chieh Wang, Jhe-Cyuan Guo, et al.
Journal of Gastroenterology and Hepatology|April 10, 2016
Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancerShih-Hung Yang, Jhe-Cyuan Guo, Kun-Huei Yeh, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 11, 2019
Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patientsShih-Hung Yang, Jhe-Cyuan Guo, Chiun Hsu, et al.
International Journal of Medical Informatics|March 25, 2026
A visualized nurse-led ePRO system for chemotherapy toxicity: Content design and validationChiao-Chi Kuan, Jhe-Cyuan Guo, Shan-Hsiang Shen, et al.
Esophagus : Official Journal of the Japan Esophageal Society|November 10, 2025
Does chemotherapy regimen matter for first-line immunochemotherapy in low PD-L1-expressing esophageal squamous cell carcinoma? A systemic review and meta-analysisJhe-Cyuan Guo, Pei-Shan Lin, Wen-Yi Shau, et al.
Medical Oncology (Northwood, London, England)|July 21, 2017
Computed tomographic characteristics for patients with unresectable gastric cancer harboring low-volume peritoneal carcinomatosisJhe-Cyuan Guo, Chin-Chen Chang, Chung-Yi Yang, et al.
Journal of Cancer Research and Clinical Oncology|August 25, 2021
Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapyTa-Chen Huang, Cher-Wei Liang, Yu-I Li, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
International Journal of Clinical Oncology|October 1, 2013
Sequential gemcitabine and platinum versus first-line combination of gemcitabine and platinum for advanced pancreatic cancer treatment: a retrospective studyJhe-Cyuan Guo, Shih-Hung Yang
Esophagus : Official Journal of the Japan Esophageal Society|January 23, 2025
Exploring novel immunotherapy in advanced esophageal squamous cell carcinoma: Is targeting TIGIT an answer?Chien-Huai Chuang, Jhe-Cyuan Guo, Ken Kato, et al.
Journal of Clinical Medicine|July 31, 2019
Postoperative Imaging and Tumor Marker Surveillance in Resected Pancreatic CancerHsu Wu, Jhe-Cyuan Guo, Shih-Hung Yang, et al.
Cancers|February 13, 2025
Impact of Membranous Nectin-4 on Outcomes of Platinum-Based Chemotherapy in Metastatic Urothelial CarcinomaFu-Jen Hsueh, Chung-Chieh Wang, Jhe-Cyuan Guo, et al.
Journal of Gastroenterology and Hepatology|April 10, 2016
Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancerShih-Hung Yang, Jhe-Cyuan Guo, Kun-Huei Yeh, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 11, 2019
Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patientsShih-Hung Yang, Jhe-Cyuan Guo, Chiun Hsu, et al.
International Journal of Medical Informatics|March 25, 2026
A visualized nurse-led ePRO system for chemotherapy toxicity: Content design and validationChiao-Chi Kuan, Jhe-Cyuan Guo, Shan-Hsiang Shen, et al.
Esophagus : Official Journal of the Japan Esophageal Society|November 10, 2025
Does chemotherapy regimen matter for first-line immunochemotherapy in low PD-L1-expressing esophageal squamous cell carcinoma? A systemic review and meta-analysisJhe-Cyuan Guo, Pei-Shan Lin, Wen-Yi Shau, et al.
Medical Oncology (Northwood, London, England)|July 21, 2017
Computed tomographic characteristics for patients with unresectable gastric cancer harboring low-volume peritoneal carcinomatosisJhe-Cyuan Guo, Chin-Chen Chang, Chung-Yi Yang, et al.
Journal of Cancer Research and Clinical Oncology|August 25, 2021
Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapyTa-Chen Huang, Cher-Wei Liang, Yu-I Li, et al.
Pageof 3